Advertisement
Advertisement
CLLS
Cellectis S.A. - ADR
2.84
USDSponsored
+0.07
+2.53%
Jul 24, 15:59 UTC -4
Closed
After-Market
2.83
-0.01
-0.35%
CLLS Earnings Reports
Positive Surprise Ratio
CLLS beat 16 of 23 last estimates.
70%
Next Report
Next Week
Date of Next Report
Jul 30, 2026
Estimate for Q2 26 (Revenue/ EPS)
$13.62M
/-$0.27
Implied change from Q1 26 (Revenue/ EPS)
+80.47%
/+50.00%
Implied change from Q2 25 (Revenue/ EPS)
-25.13%
/+12.50%
Cellectis S.A. - ADR earnings per share and revenue
On May 11, 2026, CLLS reported earnings of -0.18 USD per share (EPS) for Q1 26, beating the estimate of -0.28 USD, resulting in a 36.03% surprise. Revenue reached 7.55 million, compared to an expected 12.63 million, with a -40.26% difference. The market reacted with a -0.50% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of -0.27 USD, with revenue projected to reach 13.62 million USD, implying an increase of 50.00% EPS, and increase of 80.47% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
NovoCure Limited Ordinary Shares
Report Date
Jul 23, 2026 For Q2 26
Estimate
-$0.33
Actual
-$0.13
Surprise
+61.70%
DBV Technologies S.A.
Report Date
Jul 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.60
Surprise
-494.06%
argenx SE - ADR
Report Date
Jul 23, 2026 For Q2 26
Estimate
$6.29
Actual
$7.32
Surprise
+16.38%
Lexaria Bioscience Corp. Common Stock
Report Date
Jul 13, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+7.73%
VivoSim Labs, Inc. Common Stock
Report Date
Jul 14, 2026 For Q4 25
Estimate
-$0.19
Actual
-$2.21
Surprise
-1,040.35%
FAQ
What were Cellectis S.A. - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Cellectis S.A. - ADR reported EPS of -$0.18, beating estimates by 36.03%, and revenue of $7.55M, -40.26% below expectations.
How did the market react to Cellectis S.A. - ADR's Q1 2026 earnings?
The stock price moved down -0.5%, changed from $3.98 before the earnings release to $3.96 the day after.
When is Cellectis S.A. - ADR expected to report next?
The next earning report is scheduled for Jul 30, 2026.
What are the forecasts for Cellectis S.A. - ADR's next earnings report?
Based on 6
analysts, Cellectis S.A. - ADR is expected to report EPS of -$0.27 and revenue of $13.62M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement